Mirum Pharmaceuticals Inc
MIRM
Get informed when a big investor buys or sells
+ FollowMarket Cap$5.1B
Close$
$27.50
70.1% downside
Current Fair Value
70.1% downsideOvervalued by 70.1% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $5.10 Billion |
|---|---|
| Enterprise Value | $5.10 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.47 |
| Beta | 0.52 |
| Outstanding Shares | 58,851,021 |
Return
| Return on Equity | -329.43% |
|---|---|
| Return on Assets | -89.67% |
| Return on Invested Capital | -127.83% |
Valuation & Multiples
| P/E Ratio | -7.48 |
|---|---|
| PEG | -0.14 |
| Price to Sales | 15.31 |
| Price to Book Ratio | 22.96 |
| Enterprise Value to Revenue | 12.45 |
| Enterprise Value to EBIT | -6.46 |
| Enterprise Value to Net Income | -7 |
| Total Debt to Enterprise | 0.07 |
| Debt to Equity | 1.37 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 6, 2026
EPS Estimate
$-0.40
Average shareholder expectationRevenue Estimate
$148.21 M
Average shareholder expectationNext Earnings Call
Expected Date
July 30, 2026
EPS Estimate
$-0.74
Average shareholder expectationRevenue Estimate
$166.04 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0748▼ 14.41% |
|---|---|
| Total Calls | 215,100▲ 324.26% |
| Total Puts | 16,100▲ 45.05% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 135.96%▲ 30.92% |
|---|---|
| Total Invested | $6.29B▲ 30.56% |
| Investors Holding | 317▲ 31.00% |
ESG Score
No data